Remove patients clinical-trials-their-design-location-and-potentially-their-simulation
article thumbnail

What will the 2023 drug discovery landscape look like?

Drug Discovery World

Virtual clinical trials ‘Virtual’ and ‘technology’ are concepts which are readily exchanged in this industry, but these are more than just buzzwords. The overall virtual clinical trials market is currently valued at $7.8 The overall virtual clinical trials market is currently valued at $7.8

article thumbnail

Join DDW for the SLAS2024 Ignite Theater ‘Innovation from lab to patient’

Drug Discovery World

DDW will be hosting two conference tracks highlighting expertise in the lab to patient process. In a new feature for SLAS2024, DDW will be hosting a programme of presentations at the Ignite Theater located in the exhibition hall on 5 and 6 February: ‘Innovation & technology: from lab to patient’.

Protein 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Massive Bio Launches Industry’s First NASA-Style, Oncology Clinical Trial Command Center to Disrupt and Accelerate Trial Enrollment, Featuring 72-Hour Instant Enrollment from Time of Patient Identification

The Pharma Data

a leader in precision medicine and artificial intelligence (AI)-enabled patient-centric oncology clinical trial enrollment, announced today it has launched its SYNERGY-AI Oncology Clinical Trial Command Center (OCTCC) with the mission to disrupt and accelerate the clinical trial enrollment process.

article thumbnail

The New Buzz of Transcranial Stimulation Devices in the Neurological Disorders Market

Delveinsight

Even with the mounting prevalence, there lies a huge gap between the medical needs of the patients and available treatment with no cure at hand. Decades of research have found that neuromodulation has managed to outweigh the benefits provided by the medications, heralding it as the potential future treatment for Neurological disorders.

article thumbnail

Improving quality control for CAR T cell therapies

Drug Discovery World

Until about 25 years ago, the best treatment option for someone with blood cancer was either toxic radiation and chemotherapy or a bone marrow transplant that posed additional life-threatening risks to the patient 1. Since 2017, five CAR T cell therapies have been approved and have shown incredible success in the clinic.

article thumbnail

Solving pharma’s process development challenges one API at a time

Pharmaceutical Technology

The discovery of a new chemical entity (NCE) that could potentially lead the way to a ground-breaking therapeutic treatment is an exciting prospect for any chemist. The potential to use these scientific breakthroughs to make a real difference to patients’ lives is what drives many highly skilled scientists to the world of drug development.